search
Back to results

Self-management of Type 1 Diabetes Under Functional Insulin Therapy (EVAUTODIAB)

Primary Purpose

Type 1 Diabetes, Basal-bolus Multiple-dily Insulin Injections, Insulin Pump (CSII)

Status
Terminated
Phase
Not Applicable
Locations
France
Study Type
Interventional
Intervention
Training course to functional insulin therapy
Usual diabetes management.
Sponsored by
University Hospital, Montpellier
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional other trial for Type 1 Diabetes focused on measuring Therapeutic education, Functional insulin therapy

Eligibility Criteria

18 Years - 70 Years (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Type 1 diabetes from at least 1 year
  • Age from 18 to 70 (70 not included)
  • Basal-bolus multiple-dily insulin injections or insulin pump (CSII)
  • Informed consent
  • Affiliated or benefit from an insurance regimen

Exclusion Criteria:

  • Type 2 diabetes
  • Unable to make mathematic calculation
  • Pregnancy, breast-feeding or absence of effective contraception
  • Psychiatric and/or cognitive status uncompatible with study
  • Eating disorders
  • Law protected person, vulnerable person

Sites / Locations

  • Lapeyronie Hospital - CHU de Montpellier

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Other

Arm Label

Education to functional insulin therapy immediately

No education to functional insulin therapy immediately

Arm Description

Immediately after inclusion, patients will follow a functional insulin therapy training course during 2.5 days.

After inclusion in the study, patients go on usual diabetes management. At the end of study, they will receive education to functional insulin therapy.

Outcomes

Primary Outcome Measures

To assess the impact of therapeutic education by functional insulin therapy in patients with type 1 diabetes on their ability to disease self-management.
CIDS questionnaire

Secondary Outcome Measures

To assess the effect of education to functional insulin therapy on HbA1c level
HbA1c
To assess the effect of education to functional insulin therapy on hypoglycemia frequency
Hypoglycemia occurrence
To assess the effect of education to functional insulinotherapy on the score of each of the 20 items of CIDS questioonaire
CIDS questionnaire sub scores
To assess the validity, the concordance and the sensitivity to change of EAD questionnaire (specific for self-management of diabetes) in comparison with CIDS test
EAD questionnaire score

Full Information

First Posted
October 20, 2014
Last Updated
December 9, 2021
Sponsor
University Hospital, Montpellier
search

1. Study Identification

Unique Protocol Identification Number
NCT02272348
Brief Title
Self-management of Type 1 Diabetes Under Functional Insulin Therapy
Acronym
EVAUTODIAB
Official Title
Evaluation of Self-management of Patients With Type 1 Diabetes After Education to Functional Insulin Therapy
Study Type
Interventional

2. Study Status

Record Verification Date
December 2021
Overall Recruitment Status
Terminated
Why Stopped
Change in methodology too important - end of randomization
Study Start Date
February 10, 2015 (Actual)
Primary Completion Date
September 10, 2020 (Actual)
Study Completion Date
September 10, 2020 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
University Hospital, Montpellier

4. Oversight

Data Monitoring Committee
No

5. Study Description

Brief Summary
Therapeutic education of patients is a mandatory component of intensive insulin therapy of type 1 diabetes in order to reach optimal safety and efficacy. Used educational methods aim at facilitating patients' autonomy in their own management of diabetes. Therefore, self-management of patient with type 1 diabetes must be systematically assessed in order to evaluate the effectiveness of education programs .The main objective of this prospective controlled randomized monocentric study is to assess the impact of functional insulin therapy on the level of self-management of patients with type 1 diabetes via Confidence In Diabetes Self-care scale (CIDS) test.
Detailed Description
170 patients with type 1 diabetes, volunteering for education to functional insulin therapy, will be recruited by the Department od Endocrinology, Diabetes, Nutrition of Montpellier University Hospital. After inclusion, the patients will be randomized in 2 groups: group 1 will be immediately trained to functional insulin therapy and group 2 will be trained at the end of the study. The patients will be met as outpatients 3 months after inclusion. The primary endpoint will be the global score for CIDS questionnaire. Secondary endpoints will include: HbA1c level at month 3, frequency of hypoglycemia from inclusion to month 3, scores for each of the 20 items of CIDS questionnaire. An ancillary study will assess: the acceptability of the new EAD questionnaire which specifically evaluates the self-management of diabetes, the concordance validity of EAD and CDIS questionnaires, the reproducibility test-retest, the internal consistency and the sensitivity to change of EAD questionnaire.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Type 1 Diabetes, Basal-bolus Multiple-dily Insulin Injections, Insulin Pump (CSII)
Keywords
Therapeutic education, Functional insulin therapy

7. Study Design

Primary Purpose
Other
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
13 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Education to functional insulin therapy immediately
Arm Type
Experimental
Arm Description
Immediately after inclusion, patients will follow a functional insulin therapy training course during 2.5 days.
Arm Title
No education to functional insulin therapy immediately
Arm Type
Other
Arm Description
After inclusion in the study, patients go on usual diabetes management. At the end of study, they will receive education to functional insulin therapy.
Intervention Type
Other
Intervention Name(s)
Training course to functional insulin therapy
Intervention Description
Carbohydrate counting, carbohydrate/insulin ratio, sensitivity to insulin factor
Intervention Type
Other
Intervention Name(s)
Usual diabetes management.
Primary Outcome Measure Information:
Title
To assess the impact of therapeutic education by functional insulin therapy in patients with type 1 diabetes on their ability to disease self-management.
Description
CIDS questionnaire
Time Frame
three months (from inclusion until end of study)
Secondary Outcome Measure Information:
Title
To assess the effect of education to functional insulin therapy on HbA1c level
Description
HbA1c
Time Frame
three months (from inclusion until end of study)
Title
To assess the effect of education to functional insulin therapy on hypoglycemia frequency
Description
Hypoglycemia occurrence
Time Frame
three months (from inclusion until end of study)
Title
To assess the effect of education to functional insulinotherapy on the score of each of the 20 items of CIDS questioonaire
Description
CIDS questionnaire sub scores
Time Frame
three months (from inclusion until end of study)
Title
To assess the validity, the concordance and the sensitivity to change of EAD questionnaire (specific for self-management of diabetes) in comparison with CIDS test
Description
EAD questionnaire score
Time Frame
three months (from inclusion until end of study)

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
70 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Type 1 diabetes from at least 1 year Age from 18 to 70 (70 not included) Basal-bolus multiple-dily insulin injections or insulin pump (CSII) Informed consent Affiliated or benefit from an insurance regimen Exclusion Criteria: Type 2 diabetes Unable to make mathematic calculation Pregnancy, breast-feeding or absence of effective contraception Psychiatric and/or cognitive status uncompatible with study Eating disorders Law protected person, vulnerable person
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Elise DUTERTRE, MD
Organizational Affiliation
CHU Montpellier, France
Official's Role
Principal Investigator
Facility Information:
Facility Name
Lapeyronie Hospital - CHU de Montpellier
City
Montpellier
ZIP/Postal Code
34295
Country
France

12. IPD Sharing Statement

Learn more about this trial

Self-management of Type 1 Diabetes Under Functional Insulin Therapy

We'll reach out to this number within 24 hrs